title: [The change of fractalkine in serum and pulmonary arterioles of hypoxic rat].
abstract: OBJECTIVE
  In order to evaluate the role of fractalkine in the pathogenesis of hypoxic pulmonary hypertension, we observed the change of serum soluble fractalkine and the expression of fractalkine in pulmonary arterioles of rat at different phase of hypoxia-induced pulmonary hypertension development.
  
  
  METHODS
  The rat model of hypoxic pulmonary hypertension was duplicated by intermittent hypoxia. Mean pulmonary arterial pressure (mPAP) was measured by a right cardiac catheterization. The thickness of pulmonary arterioles was measured with a computerized image analyzer. Serum soluble fractalkine concentrations were measured by enzyme-linked immunosorbent assay. The expressions of fractalkine mRNA and protein in pulmonary arterioles were detected by in situ hybridization and immunohistochemical analysis, respectively.
  
  
  RESULTS
  Compared to control, the mPAP of rats was markedly elevated after hypoxia for 14 days (P < 0.01), but the index of wall thickness of pulmonary arterioles (WT% and WA%) and the index of right ventricular hypertrophy CRV/(LV+S)] increased significantly at 21 days of hypoxia (P < 0.01). In rats exposed to hypoxia for 21 days, the fractalkine mRNA and protein levels in pulmonary arterioles were up-regulated significantly (P < 0.01), and the serum soluble fractalkine concentrations were also elevated (P < 0.01), as compared with control. Linear correlation analysis showed that the fractalkine mRNA level in pulmonary arterioles was associated with WA% (r = 0.749, P < 0.01) and WT% (r = 0.732, P < 0.01), the fractalkine protein level in pulmonary arterioles was also correlated with WA% (r = 0.727, P < 0.01) and WT% (r = 0.683, P < 0.01).
  
  
  CONCLUSIONS
  The chronic hypoxia stimulates the synthesis and release of fractalkine. Fractalkine plays an important role in regulating the pulmonary vascular remodeling.
authors.affiliation: Department of Respiratory Medicine, West China Hospital, Sichuan University, Chengdu 610041, China.
authors.forename: Xiao-ju
authors.initials: XJ
authors.lastname: Chen
authors.forename: De-yun
authors.initials: DY
authors.lastname: Cheng
authors.forename: Li
authors.initials: L
authors.lastname: Yang
authors.forename: Xiu-qiong
authors.initials: XQ
authors.lastname: Xia
mesh_terms: D000818:Animals; D001160:Arterioles / Q000378:metabolism*; D054428:Chemokine CX3CL1 / Q000097:blood*; D004195:Disease Models, Animal; D006976:Hypertension, Pulmonary / Q000378:metabolism*; D000860:Hypoxia / Q000378:metabolism*; D008168:Lung / Q000098:blood supply* / Q000473:pathology; D051381:Rats; D017207:Rats, Sprague-Dawley
chemical_list: D054428:Chemokine CX3CL1; C515540:Cx3cl1 protein, rat